🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial studies how well birinapant and carboplatin work in t...
Status
Withdrawn
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2018-08-01
Trial ID
NCT02756130
Treatments Being Tested
This is a dose escalation safety study of birinapant (TL32711) in combinati...
Status
Completed
Location
Holy Cross Hospital
Start Date
2010-10
Trial ID
NCT01188499
Treatments Being Tested
Background: \- Birinapant is an experimental cancer treatment drug. It rem...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2012-08-15
Trial ID
NCT01681368
Treatments Being Tested
This is a dose escalation study in female subjects with relapsed ovarian ca...
Status
Completed
Location
TetraLogic research site
Start Date
2013-11
Trial ID
NCT01940172
Treatments Being Tested
This is a dose escalation followed by dose expansion study of TL32711 in co...
Status
Completed
Location
Palo Verde Hematology Oncology
Start Date
2013-06
Trial ID
NCT01828346
Treatments Being Tested
The purpose of this study is to determine the dose of smac mimetic TL32711 ...
Status
Terminated
Location
Roswell Park Cancer Institute
Start Date
2012-04
Trial ID
NCT01573780
This is a randomized double blind placebo controlled study of azacitidine w...
Status
Terminated
Location
Palo Verde Hematology Oncology
Start Date
2014-06
Trial ID
NCT02147873
Treatments Being Tested
This study is a first-in-human, Phase 1a/1b, multicenter, open-label study ...
Status
Terminated
Location
Mayo Clinic
Start Date
2020-09-23
Trial ID
NCT04553692
A Phase 1 open-label, non-randomized dose escalation study to determine the...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2009-11
Trial ID
NCT00993239
Treatments Being Tested
This was initially a phase I/II, open-label non-randomized study using an i...
Status
Terminated
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2011-11
Trial ID
NCT01486784
Treatments Being Tested